CD70 demonstrates pathognomonic overexpression across diverse solid and hematologic neoplasms,20 inducing co-stimulation and promoting the differentiation of cytotoxic T lymphocyte cells. This evidence concerns the gene CD70 and hematopoietic and lymphoid system neoplasm.